Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18746471 | STENT DELIVERY SYSTEM HAVING RETENTION STRUCTURE | June 2024 | February 2025 | Allow | 7 | 0 | 0 | No | No |
| 18662078 | METHOD AND DEVICE FOR SIMULTANEOUSLY DOCUMENTING AND TREATING TENSION PNEUMOTHORAX AND/OR HEMOTHORAX | May 2024 | May 2025 | Allow | 12 | 1 | 0 | No | No |
| 18632872 | TISSUE PROCESSING APPARATUS AND METHOD FOR PROCESSING ADIPOSE TISSUE | April 2024 | May 2025 | Abandon | 14 | 1 | 0 | No | No |
| 18606266 | PYLORIC ANCHORS AND METHODS FOR INTESTINAL BYPASS SLEEVES | March 2024 | June 2025 | Abandon | 15 | 1 | 0 | No | No |
| 18537989 | LOW PROFILE DISTRIBUTION COMPONENTS FOR WOUND THERAPY | December 2023 | February 2025 | Allow | 14 | 0 | 0 | No | No |
| 18526402 | PERCUTANEOUS ACCESS PATHWAY SYSTEM AND METHOD | December 2023 | November 2024 | Allow | 11 | 0 | 0 | No | No |
| 18510399 | ASPIRATION PUMP FOR REMOVAL OF FLUIDS, BLOOD CLOTS AND OTHER MATERIALS FROM HUMAN BODY | November 2023 | April 2024 | Allow | 5 | 1 | 0 | Yes | No |
| 18510516 | VIAL ASSEMBLY WITH LUER FITTING | November 2023 | August 2024 | Allow | 9 | 0 | 0 | No | No |
| 18388200 | Negative Pressure Therapy Systems and Sponges | November 2023 | August 2024 | Allow | 10 | 1 | 0 | No | No |
| 18280122 | A TAMPER PROOF LUER LOCK CONNECTOR AND A VALVE ARRANGEMENT FOR AN ADAPTOR | September 2023 | June 2024 | Allow | 10 | 0 | 0 | No | No |
| 18363981 | SECURED MEDICATION TRANSFER SYSTEM | August 2023 | April 2025 | Allow | 20 | 2 | 0 | No | No |
| 18140652 | HEART HELP DEVICE, SYSTEM, AND METHOD | April 2023 | August 2024 | Allow | 16 | 1 | 0 | No | No |
| 18140050 | SYSTEMS AND METHODS FOR DRAINING CEREBROSPINAL FLUID | April 2023 | February 2024 | Allow | 9 | 2 | 0 | Yes | No |
| 18110735 | Flow Indwelling Urinary Catheter | February 2023 | March 2024 | Abandon | 13 | 1 | 0 | No | No |
| 18156822 | INTRAOCULAR SHUNT IMPLANTATION METHODS AND DEVICES | January 2023 | October 2024 | Abandon | 20 | 1 | 0 | No | No |
| 18011027 | CLOSED SYSTEM TRANSFER DEVICE | December 2022 | April 2025 | Allow | 28 | 0 | 0 | No | No |
| 17985751 | STENT DELIVERY SYSTEM HAVING RETENTION STRUCTURE | November 2022 | March 2024 | Allow | 16 | 0 | 0 | No | No |
| 18052650 | OSTOMY OUTPUT DIVERSION DEVICE | November 2022 | April 2025 | Allow | 29 | 0 | 0 | No | No |
| 17937574 | EXHAUST COLLECTION BAG FOR CRYOGENIC TREATMENT | October 2022 | September 2024 | Allow | 24 | 0 | 0 | No | No |
| 17957739 | WOUND THERAPY SYSTEM WITH INTERNAL ALTERNATING ORIFICE | September 2022 | June 2025 | Allow | 33 | 1 | 1 | No | No |
| 17950614 | ABSORBENT ARTICLE WITH BODY CONFORMING STRUCTURE | September 2022 | December 2024 | Allow | 26 | 2 | 0 | No | No |
| 17943598 | Waste Collection System With Controllers For Regulating Levels Of Vacuum Drawn On A Waste Container | September 2022 | October 2024 | Allow | 25 | 0 | 0 | Yes | No |
| 17902373 | Medication Dose Preparation and Transfer System | September 2022 | March 2025 | Allow | 31 | 1 | 0 | No | No |
| 17889673 | SYSTEM AND METHOD FOR DRAINING CEREBROSPINAL FLUID IN HYDROCEPHALUS PATIENTS | August 2022 | June 2024 | Allow | 22 | 1 | 0 | No | No |
| 17877358 | URETHRAL CATHETERS AND METHODS FOR FACILITATED INTRODUCTION INTO THE URINARY TRACT | July 2022 | October 2024 | Abandon | 26 | 1 | 0 | No | No |
| 17873877 | WOUND THERAPY SYSTEM WITH WOUND VOLUME ESTIMATION | July 2022 | April 2025 | Allow | 33 | 2 | 1 | Yes | No |
| 17871868 | NEGATIVE PRESSURE WOUND THERAPY APPARATUSES AND METHODS FOR USING THE SAME | July 2022 | May 2024 | Allow | 22 | 0 | 0 | No | No |
| 17851562 | ANTIMICROBIAL LIGHT-EMITTING OROPHARYNGEAL DEVICE FOR VENTILATOR-ASSOCIATED PNEUMONIA | June 2022 | August 2023 | Abandon | 13 | 4 | 0 | No | No |
| 17843139 | METHOD AND DEVICE FOR SIMULTANEOUSLY DOCUMENTING AND TREATING TENSION PNEUMOTHORAX AND/OR HEMOTHORAX | June 2022 | February 2024 | Allow | 20 | 0 | 0 | No | No |
| 17745544 | SYSTEMS, METHODS AND HANDHELD PULSATILE ASPIRATION AND INJECTION DEVICES | May 2022 | March 2025 | Abandon | 34 | 1 | 1 | No | No |
| 17774310 | ADJUSTABLE SHUNTING SYSTEMS WITH PLATE ASSEMBLIES, AND ASSOCIATED SYSTEMS AND METHODS | May 2022 | August 2023 | Allow | 16 | 0 | 1 | No | No |
| 17670215 | FLUID DELIVERY ALIGNMENT SYSTEM | February 2022 | January 2025 | Allow | 35 | 2 | 0 | No | No |
| 17668480 | MEMBRANE AND DEVICE FOR TREATING RESTLESS LEG SYNDROME | February 2022 | April 2024 | Allow | 26 | 1 | 0 | No | No |
| 17590357 | Protector Housing Plastic Spike with Flash Intended for DVO Last Drop Extraction | February 2022 | November 2024 | Allow | 33 | 1 | 0 | No | No |
| 17580865 | TISSUE PROCESSING APPARATUS AND METHOD FOR PROCESSING ADIPOSE TISSUE | January 2022 | May 2024 | Abandon | 28 | 1 | 0 | No | No |
| 17580448 | HANDHELD FILAMENT EXTENSION ATOMIZER FOR PRECISION DELIVERY OF DRUGS AND THERAPEUTICS | January 2022 | June 2025 | Allow | 41 | 1 | 0 | No | No |
| 17645520 | BALLOON CATHETER | December 2021 | February 2024 | Allow | 26 | 1 | 0 | No | No |
| 17555688 | Manifold For A Medical Waste Collection System | December 2021 | March 2025 | Allow | 39 | 0 | 0 | No | No |
| 17555195 | METHOD AND APPARATUS FOR PROVIDING NEGATIVE PRESSURE TO A NEGATIVE PRESSURE WOUND THERAPY BANDAGE | December 2021 | July 2024 | Allow | 31 | 2 | 0 | Yes | No |
| 17549127 | Lipoaspirate Processing | December 2021 | August 2022 | Allow | 9 | 1 | 0 | Yes | No |
| 17617072 | FLUID TRANSFER SYSTEM AND COMPONENTS THEREFOR | December 2021 | March 2025 | Abandon | 40 | 6 | 0 | Yes | No |
| 17615717 | SUCTION BOTTLE FOR THROMBUS ASPIRATOR AND THROMBUS ASPIRATOR | December 2021 | August 2024 | Allow | 32 | 2 | 0 | No | No |
| 17490395 | CLIP FOR URINARY DRAINAGE SYSTEM | September 2021 | December 2021 | Allow | 3 | 0 | 0 | Yes | No |
| 17489660 | Bone Dust Collection Cap and Plunger Assembly | September 2021 | March 2022 | Allow | 5 | 0 | 1 | No | No |
| 17478995 | Removal Of Microbubbles Through Drip Chamber Nucleation Sites | September 2021 | April 2024 | Allow | 31 | 2 | 0 | No | No |
| 17375040 | OSTOMY APPLIANCE HAVING AN ALARM FOR SENSED MOISTURE | July 2021 | June 2025 | Abandon | 47 | 2 | 1 | No | No |
| 17370965 | Reduced-Pressure, Tunnel-Wound Dressings, Systems, And Methods | July 2021 | August 2024 | Abandon | 37 | 0 | 1 | No | No |
| 17418861 | VALVE FOR PERMANENT IMPLANTATION, IN PARTICULAR FOR TREATMENT OF NORMAL PRESSURE HYDROCEPHALUS | June 2021 | February 2025 | Allow | 43 | 1 | 1 | No | No |
| 17353132 | DEVICE FOR APPLYING LIQUID MEDICAL SUBSTANCES | June 2021 | February 2024 | Allow | 32 | 1 | 0 | No | No |
| 17343066 | CANALICULAR PLUG, METHOD AND KIT FOR TREATING DRY EYE | June 2021 | November 2021 | Allow | 5 | 1 | 0 | No | No |
| 17326081 | SYSTEMS AND METHODS FOR DELIVERY OF A THERAPEUTIC AGENT | May 2021 | May 2024 | Abandon | 36 | 1 | 0 | No | No |
| 17321296 | LOW POWER, CHEMICALLY AMPLIFIED, ELECTRICALLY REMOVABLE BARRIER | May 2021 | October 2023 | Allow | 29 | 0 | 0 | No | No |
| 17314129 | Tubing Connection Adaptor System | May 2021 | March 2025 | Abandon | 46 | 2 | 0 | No | No |
| 17307279 | Blood pump and oxygenator combination. | May 2021 | December 2024 | Abandon | 43 | 2 | 1 | No | No |
| 17233765 | APPLICATORS, COMPOSITIONS AND METHODS FOR CLEANSING AN OCULAR AREA | April 2021 | February 2025 | Abandon | 46 | 2 | 0 | No | No |
| 17228901 | METHOD FOR REDUCING BIOFILM FORMATION | April 2021 | August 2023 | Allow | 28 | 1 | 0 | No | No |
| 17226839 | SYSTEMS AND METHODS FOR COUPLING AND DECOUPLING A CATHETER | April 2021 | October 2024 | Allow | 42 | 1 | 1 | No | No |
| 17280346 | DRAINAGE DEVICE WITH PRESSURE RELIEF VALVE | March 2021 | March 2023 | Abandon | 23 | 2 | 0 | No | No |
| 17199532 | ACUTE GLAUCOMA DEVICE | March 2021 | April 2024 | Allow | 37 | 2 | 1 | No | No |
| 17193962 | SYSTEMS AND METHODS FOR ASPIRATING FROM A BODY LUMEN | March 2021 | August 2023 | Allow | 29 | 1 | 0 | No | No |
| 17179116 | USING WICKING MATERIAL TO COLLECT LIQUID FOR TRANSPORT | February 2021 | September 2024 | Allow | 43 | 3 | 0 | Yes | No |
| 17176580 | METHOD OF USING A CATHETER WITH A DEDICATED FLUSHING PORT | February 2021 | November 2023 | Abandon | 32 | 1 | 0 | No | No |
| 17172262 | Polychromatic Phototherapy Device and Method | February 2021 | May 2024 | Allow | 39 | 1 | 1 | Yes | No |
| 17165992 | Negative Pressure Therapy Systems and Sponges | February 2021 | August 2023 | Allow | 30 | 1 | 0 | No | No |
| 17166543 | METHODS AND DEVICES FOR MANIPULATING SUBDERMAL FAT | February 2021 | May 2025 | Abandon | 51 | 2 | 1 | No | No |
| 17264280 | Puncture Device to be Used in Creating a TIPS Shunt | January 2021 | April 2024 | Allow | 38 | 4 | 0 | Yes | Yes |
| 17142707 | PACKAGING ASSEMBLY FOR STORING TISSUE AND CELLULAR MATERIAL | January 2021 | April 2023 | Allow | 27 | 0 | 1 | No | No |
| 17140820 | METHOD FOR THE PERCUTANEOUS CREATION OF AN ARTERIOVENOUS FISTULA (AVF) | January 2021 | July 2025 | Allow | 54 | 3 | 0 | No | No |
| 17129642 | METHOD FOR PREPARING A PRODUCT COMPRISING STROMAL VASCULAR FRACTION CELLS | December 2020 | January 2023 | Allow | 25 | 0 | 0 | No | No |
| 17247466 | PERCUTANEOUS ACCESS PATHWAY SYSTEM AND METHOD | December 2020 | August 2023 | Allow | 32 | 2 | 0 | No | No |
| 17101388 | Flushable Disintegration Catheter | November 2020 | September 2024 | Allow | 46 | 3 | 0 | Yes | No |
| 17089407 | WOUND TREATMENT APPARATUSES AND METHODS FOR CONTROLLED DELIVERY OF FLUIDS TO A WOUND | November 2020 | April 2023 | Allow | 29 | 0 | 0 | No | No |
| 17072967 | PRESSURE-REGULATING VIAL ADAPTORS | October 2020 | August 2023 | Allow | 34 | 2 | 0 | Yes | No |
| 17068090 | OPEN WOUND NEGATIVE PRESSURE WOUND THERAPY PROTECTION SYSTEM | October 2020 | March 2023 | Abandon | 29 | 2 | 0 | No | No |
| 17032111 | BLOOD TREATMENT DEVICE WITH AUTOMATIC SUBSTITUTION VOLUME COMPENSATION | September 2020 | April 2025 | Abandon | 55 | 3 | 0 | No | No |
| 17014729 | Methods of Applying a Hydrophilic Coating to a Substrate, and Substrates Having a Hydrophilic Coating | September 2020 | August 2023 | Abandon | 35 | 1 | 0 | No | No |
| 16997356 | Device for Treating Glaucoma | August 2020 | March 2023 | Allow | 31 | 2 | 0 | No | No |
| 16992795 | MICROPLEGIA DELIVERY SYSTEM | August 2020 | July 2025 | Allow | 59 | 4 | 1 | No | No |
| 16987137 | PRESERVATIVE REMOVAL FROM EYE DROPS | August 2020 | February 2023 | Allow | 31 | 1 | 0 | No | No |
| 16983530 | PYLORIC ANCHORS AND METHODS FOR INTESTINAL BYPASS SLEEVES | August 2020 | March 2024 | Abandon | 44 | 3 | 0 | No | No |
| 16966989 | CHEMICAL PUMP HOUSING FOR NEGATIVE PRESSURE SYSTEM | August 2020 | June 2021 | Allow | 10 | 1 | 0 | No | No |
| 16944550 | WOUND CARE AND INFUSION METHOD AND SYSTEM UTILIZING A THERAPEUTIC AGENT | July 2020 | March 2023 | Abandon | 31 | 1 | 0 | No | No |
| 16944466 | System And Method For Valve Control | July 2020 | April 2024 | Allow | 44 | 2 | 1 | No | No |
| 16961854 | SYSTEMS AND METHODS FOR CONTROLLING NEGATIVE PRESSURE THERAPY WITH FLUID INSTILLATION THERAPY AND CLEANSING | July 2020 | August 2023 | Abandon | 37 | 2 | 0 | No | No |
| 16919401 | SURGICAL INSTRUMENT AND METHOD FOR GONIOTOMY PROCEDURE | July 2020 | April 2024 | Allow | 45 | 2 | 1 | No | Yes |
| 16895323 | TRANSFER DEVICE | June 2020 | June 2024 | Allow | 48 | 3 | 0 | No | No |
| 16890133 | Drainage Catheter System Including a Hub | June 2020 | December 2022 | Allow | 30 | 0 | 0 | No | No |
| 16888891 | Heart assisting device | June 2020 | January 2023 | Allow | 31 | 1 | 0 | No | No |
| 16878012 | ABSORBENT ARTICLE WITH BODY CONFORMING STRUCTURE | May 2020 | June 2022 | Allow | 25 | 0 | 0 | No | No |
| 16875587 | SUPER-ABSORBENT, REDUCED-PRESSURE WOUND DRESSING AND SYSTEMS | May 2020 | August 2023 | Allow | 39 | 1 | 1 | No | No |
| 16763365 | VIAL ADAPTOR ASSEMBLY FOR A CLOSED FLUID TRANSFER SYSTEM | May 2020 | September 2022 | Allow | 29 | 0 | 0 | Yes | No |
| 16865908 | GEL DISTRIBUTOR IN URINARY CATHETER PACKAGE | May 2020 | July 2022 | Allow | 26 | 0 | 0 | No | No |
| 16859747 | FLOW INDWELLING URINARY CATHETER | April 2020 | March 2023 | Abandon | 35 | 6 | 0 | Yes | No |
| 16828193 | SLEEVE TUBE AND METHOD OF USE | March 2020 | August 2023 | Abandon | 41 | 2 | 0 | No | No |
| 16826858 | APPARATUS AND METHODS FOR TREATING EXCESS INTRAOCULAR FLUID | March 2020 | March 2023 | Allow | 36 | 1 | 0 | No | No |
| 16813687 | Occlusive Chest Wound Seal with a One-Way Vent for Preventing and Treating Tension Pneumothorax | March 2020 | December 2022 | Allow | 34 | 1 | 0 | No | No |
| 16644492 | SUTURE-LESS CHEST TUBE | March 2020 | March 2022 | Abandon | 24 | 1 | 0 | No | No |
| 16803203 | Manifold For A Medical Waste Collection System | February 2020 | January 2025 | Allow | 59 | 4 | 0 | Yes | No |
| 16797101 | STENT DELIVERY SYSTEM HAVING RETENTION STRUCTURE | February 2020 | August 2022 | Allow | 29 | 0 | 0 | Yes | No |
| 16788180 | Suction Canister and Corresponding Systems and Methods | February 2020 | November 2022 | Allow | 33 | 0 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WENG, KAI H.
With a 75.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 46.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner WENG, KAI H works in Art Unit 3781 and has examined 363 patent applications in our dataset. With an allowance rate of 77.7%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 35 months.
Examiner WENG, KAI H's allowance rate of 77.7% places them in the 37% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by WENG, KAI H receive 1.93 office actions before reaching final disposition. This places the examiner in the 62% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by WENG, KAI H is 35 months. This places the examiner in the 21% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +14.5% benefit to allowance rate for applications examined by WENG, KAI H. This interview benefit is in the 57% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 24.6% of applications are subsequently allowed. This success rate is in the 27% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 21.2% of cases where such amendments are filed. This entry rate is in the 19% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 80.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 62% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 75.0% of appeals filed. This is in the 62% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 38.8% are granted (fully or in part). This grant rate is in the 36% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 42% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 42% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.